Anju Peters, MD

Articles by Anju Peters, MD

EVEREST: Dupilumab Outperforms Omalizumab in Head-to-Head CRSwNP Trial, with Anju Peters, MD

ByAnju Peters, MD

October 8th 2025

Peters emphasized how the new findings reinforce treatment strategies for chronic rhinosinusitis with nasal polyps.

Final Thoughts on Management of Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

December 22nd 2022

Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri share takeaway thoughts on the management of nasal polyposis.

Unmet Needs in Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

December 22nd 2022

Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri review unmet needs and shared decision making in the treatment of nasal polyposis.

Emerging Treatment Options for Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

December 22nd 2022

A multidisciplinary panel reviews emerging treatment options for nasal polyposis, including EDS-FLU, Tezepelumab, and Rimegepant.

Use of Clinical Trials for Patients with Nasal Polyps

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

December 15th 2022

Drs Anju Peters and Naveen Bhandarkar, comment on the challenges of using biologic therapies to treat patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP).

Challenges in the Use of Biologics for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

December 15th 2022

Drs Anju Peters and Naveen Bhandarkar, comment on the challenges of using biologic therapies to treat patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP).

Biologics for Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

December 8th 2022

A panel of experts highlights the role of biologics in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Changing Treatment for Patients with Nasal Polyps

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

December 8th 2022

Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri discuss their approach to changing treatment for patients with chronic rhinosinusitis either with or without nasal polyps.

Role of EDS-FLU in Clinical Practice in Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

December 1st 2022

A multidisciplinary panel discusses the role of EDU-FLU in their individual practices.

Use of Steroids After Surgery in Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

December 1st 2022

Drs Anju Peters and Naveen Bhandarkar comment on the use of steroids after surgery for nasal polyposis.

EDS-PLU Studies for Treatment of Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

November 24th 2022

Expert allergists provide an overview of the phase 3 studies with EDS-FLU for treatment of nasal polyposis.

Use of Steroid Eluting Stents in Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

November 24th 2022

Naveen Bhandarkar, MD, shares his thoughts on the role of steroid eluting stents in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Bioabsorbable Sinus Implants for Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

November 17th 2022

Naveen Bhandarkar, MD, discusses the use of sinus implants for the treatment of nasal polyposis.

Large Volume Corticosteroid Delivery System for Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

November 17th 2022

Andrew White, MD, reviews large volume corticosteroid delivery devices for patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Small Volume Corticosteroid Delivery Systems for Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

November 10th 2022

Dareen Siri, MD, FAAAAI, FACAAI, highlights small volume corticosteroid delivery systems for patients with nasal polyps and Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).

Treatment Options for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

November 10th 2022

Dareen Siri, MD, FAAAAI, FACAAI, discusses the treatment options available for Nasal Polyposis.

Guidelines for Diagnosis and Treatment of Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

November 3rd 2022

Drs Anju Peters, Naveen Bhandarkar, Andrew White, and Dareen Siri review guidelines and position statements for diagnosis and management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Chronic Rhinosinusitis without Nasal Polyps (CRSsNP).

Role of Various Specialists in Diagnosis and Management of Nasal Polyposis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

November 3rd 2022

An expert panel discusses a multidisciplinary approach to the diagnosis and management of nasal polyposis.

Comorbidities with Chronic Rhinosinusitis

ByAnju Peters, MD,Naveen Bhandarkar, MD,Andrew White, MD,Dareen Siri, MD, FAAAAI, FACAAI

October 27th 2022

Andrew White, MD, and Dareen Siri, MD, FAAAAI, FACAAI, discuss the comorbidities chronic rhinosinusitis with nasal polyps (CRSwNP) can be associated with.